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Abstract Specific language impairment (SLI) is a multifac-
torial neurodevelopmental disorder which occurs unexpected-
ly and without an obvious cause. Over a decade of research
suggests that SLI is highly heritable. Several genes and loci
have already been implicated in SLI through linkage and
targeted association methods. Recently, genome-wide associ-
ation studies (GWAS) of SLI and language traits in the general
population have been reported and, consequently, new candi-
date genes have been identified. This review aims to summa-
rise the literature concerning genome-wide studies of SLI. In
addition, this review highlights the methodologies that have
been used to research the genetics of SLI to date, and also
considers the current, and future, contributions that GWAS
can offer.
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Neurodevelopmental Disorders
Introduction
The term ‘language impairment’ (LI) encompasses a wide
range of disorders that can impair, or delay, both verbal and
written language abilities. Specific language impairment (SLI)
is one such disorder. It occurs in 5–8 % of English-speaking
school children and is an example of a verbal language im-
pairment [1, 2]. SLI occurs despite adequate intelligence,
access to education and no major neurological deficit [3]. A
diagnosis is reliant on exclusion of disorders that might cause
the language impairment, such as autism, cerebral palsy, hear-
ing loss or intellectual disability [4]. The aetiology of SLI, like
that of many complex neurological disorders, is not well
defined, but research over the last decade has provided us
with strong evidence to support the likelihood of a polygenic
genetic basis [5–13, 14•]. Although it might be expected that
factors such as language input would impact a child’s likeli-
hood of developing SLI, studies have shown that most chil-
dren learn to talk competently even if they are taught by adults
with language impairment. This suggests that, in comparison
with genes, language input has little influence on a child’s risk
of developing SLI [3].
Methodologies
Early genetic studies of SLI have been dominated by quanti-
tative trait loci (QTL) mapping and genome-wide linkage
analysis (GWLA) methodologies. Linkage studies rely on
family data, aim to identify regions of the genome that are
shared between related affected individuals [15] and can be
either parametric or non-parametric. Parametric studies re-
quire definition of an inheritance model (e.g. dominant or
recessive), penetrance and allele frequencies, while non-
parametric methods are, for the most part, model free [15].
The specification of a model for SLI is not always
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straightforward; SLI tends to run in families and is considered
to be highly heritable [16], but it only rarely follows a mono-
genic inheritance pattern [13]. This sporadic form of inheri-
tance suggests that a collection of genes are at least partly
responsible for the manifestation and severity of SLI in affect-
ed individuals [12]. Linkage studies may be limited in their
application to complex genetic disorders because of their low
resolution and pedigree limitations. Nonetheless, they can be
conducted using small sample sizes and can effectively reduce
the number of candidate regions to consider in preparation for
targeted association analyses [17]. In contrast to linkage stud-
ies, association analyses have a high resolution and directly
implicate specific genetic variants by comparing allele fre-
quencies between cases and controls. Significantly associated
variants would likely either be in linkage disequilibrium (LD)
with the causal variant or be the causative variant themselves.
Unlike linkage studies, association analyses assume that the
causal variant will be constant across cases and will occur at a
reduced frequency in controls. This can be a limiting factor, as
complex disorders such as SLI are likely to involve a variable
combination of variants (genetic heterogeneity), even within
the same gene. In addition to case–control methods, associa-
tion methods can be applied within family-based cohorts by
comparison of allele frequencies between probands and unaf-
fected family members [13].
SLI GWLA Studies
Two initial GWLA studies of SLI identified novel candidate
regions that are linked to performance on tests of language-
related ability, in families affected by SLI [5–7]. The first
study, conducted by the SLI Consortium (SLIC), identified
two novel susceptibility loci on chromosomes 16q23–24
(SLI1, OMIM 606711) and 19q13 (SLI2, OMIM 606712)
[6]. A subsequent study by Bartlett et al. highlighted 13q21
(SLI3, OMIM 607134) and 2p22 as additional loci predispos-
ing to SLI [7].
SLIC analysed 98 UK families (473 individuals), each with
a proband whose language scores fell ≥1.5 standard deviation
(SD) below the mean for their age and nonverbal IQ scores
that were within the specified normal range (>80). This study
considered three quantitative language measures derived from
the Clinical Evaluation of Language Fundamentals—Revised
(CELF-R) and non-word repetition (NWR) [6]. CELF-R is a
commonly used test battery designed to assess both receptive
and expressive language ability in school-age children [18].
The NWR test measures the ability to retain novel phonolog-
ical (speech sound) information for short periods of time; this
is commonly impaired in people with SLI [5, 11]. Following
the language tests, linkage analysis was performed using 400
highly polymorphic microsatellite markers. Significant link-
age was detected on chromosome 16 with the NWR trait
(LOD score 3.55; P=0.00003) and on chromosome 19 with
the CELF-R expressive language score [ELS] (LOD score
3.55; P=0.0004) [6].
Bartlett et al. analysed five Canadian families (including 73
individuals) of Celtic ancestry. Individuals were sorted into
three categorical groups, labelled ‘language-impaired’, ‘read-
ing-impaired’ and ‘clinically impaired’ on the basis of their
performance across six quantitative language tests. Language-
impaired individuals were defined by a Spoken Language
Quotient (SLQ) score (from the Test of Language Develop-
ment) [19] of ≤85, reading-impaired individuals had a non-
word reading and IQ discrepancy, and clinically impaired
individuals had a history of speech and/or reading therapy
[7, 8]. Linkage to region 13q21 was detected under a recessive
model in the reading-impaired group (LOD score 3.92;
P<0.01), and linkage to 2p22 was detected under a recessive
model of the language-impaired group (LOD score 2.86;
P<0.06) [7].
The lack of overlap between the SLI susceptibility regions,
implicated by these two independent linkage studies, not only
supports the theory of locus heterogeneity but also demon-
strates the statistical complexity of replicating genetic loci in
different cohorts with variable phenotypes. Susceptibility re-
gions 13q21 and 2p22, highlighted by Bartlett et al., may not
have been detected by SLIC, because of alternative allele
frequencies within the UK sample set. Although the Canadian
families in the study by Bartlett et al. were not considered
population isolates, they were selected from a different ethnic
background compared with that of the SLIC cohort, and thus
the markers carried in these regions may have been elevated to
a detectable linkage peak in this group. Furthermore, SLIC
and Bartlett utilised slightly different linkage methodologies
and diagnostic criteria for determining SLI affection status.
SLIC diagnosed probands on the basis of a clinical verbal-
language battery [5, 6], whereas Bartlett included a more
varied set of phenotypes, including reading ability (de-
signed to reflect the proband’s overall language ability),
and then classified all individuals as being affected or
unaffected under three alternative definitions [7, 8].
SLIC used non-parametric linkage methods, whereas
Bartlett used parametric linkage, assuming 7 % popula-
tion penetrance, and used both dominant and recessive
models of inheritance [5–8].
Despite the inconsistency of loci linked to SLI, both SLIC
and Bartlett have since replicated their findings [5, 8]. SLIC
conducted a targeted linkage study in 2004, with an additional
86 nuclear families selected and characterised as described for
the SLIC samples above. Linkage was detected again on
chromosomes 16 (LOD score 2.86; P<0.02) and 19 (LOD
score 2.31; P<0.02), both to the NWR trait. The two SLIC
cohorts were then pooled to total 184 families and 840 indi-
viduals. In this pooled dataset, highly significant linkage was
detected on chromosome 16 [5].
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In 2007, SLIC applied a genome-wide multivariate linkage
approach to their pooled cohort, which was able to analyse
linkage to multiple quantitative traits simultaneously. In total,
they investigated 11 measures of spoken and receptive lan-
guage ability, reading ability and non-verbal IQ. This study
supported the Consortium’s previous evidence linking loci on
chromosomes 16q (P=0.008) and 19q (P=0.017), and
highlighted a novel region of linkage on chromosome 10q26
(P=0.019) [9]. The linkage on chromosome 16q was specific
to NWR in the previous univariate SLIC studies, and in the
multivariate study it was linked to NWR and literacymeasures
(single-word reading and single-word spelling) [5, 6, 9], indi-
cating that variation in this region will likely impact phono-
logical memory. An inability to store short-term verbal infor-
mation is likely to impair the ability of an individual to acquire
and retain language skills, and this has been a growing,
aetiological theory surrounding SLI [20, 21]. In contrast,
linkage to chromosome 19q had previously been detected
with multiple traits, firstly to ELS [6], then to NWR [5], and
in the multivariate study it was found to be linked to a variety
of expressive and language traits [9]. This suggests that the
risk variants within this linkage region may impact upon a
variety of language abilities.
One final study further expanded the SLIC cohort,
analysing an additional 300 individuals from 93 families
affected by SLI, and again replicated linkage of chromosome
16q (P=0.002) with NWR, and linkage of chromosome 19q
(P=0.007) with ELS [22].
Bartlett et al. also expanded their cohort to include 22 US-
based nuclear families with at least one individual per family
affected by SLI, in combination with the original families
studied [8]. In total, 365 DNA samples were genotyped for
microsatellites on chromosomes 2 and 13, enabling replica-
tion of the chromosome region 13q21 linkage, using similar
parametric modelling procedures. Further analysis revealed
that only a small percentage of the families contributed to this
linkage, suggesting that the risk factor is not sufficient or
necessary for SLI to manifest itself in all families. In this
combined sample set, the linkage region on chromosome 2
could not be replicated, suggesting that if SLI risk factors exist
on chromosome 2, they may have a small effect size with low
penetrance, which would make them difficult to identify using
a linkage study [8].
In addition to the SLIC and Bartlett studies, a few other
groups have also investigated the genetic basis of SLI, using
single families and isolated populations [12, 23, 24, 25•].
These studies provided a unique opportunity to look at indi-
viduals with an increased level of shared environmental and
genetic influences. When certain phenotypes become more
prevalent in isolated populations, it may suggest that a
founding genetic influence has been shared amongst the group
and may thus be more common and somewhat easier to
identify.
A classic linkage study, conducted prior to the two de-
scribed above, linked language impairment to a region desig-
nated SPCH1 on chromosome 7q [26, 27]. This study
analysed a single, large, three-generation pedigree known as
the KE family, in which approximately half of the individuals
were affected with a severe speech and language disorder.
GWLA identified a region on chromosome 7q31 (maximum
LOD score 6.62) that co-segregated with the language disor-
der in this particular family [26] and has since been narrowed
down to a causative mutation in the FOXP2 (forkhead box P2)
gene (OMIM 605317) [24]. It is important to note that not all
members of the KE family would meet the selection criteria
for studies of specific language impairment, because they had
evidence of both intellectual disability and motor impairment.
In addition, the severe language impairment exhibited by
members of the KE family surpasses the typical SLI pheno-
type, in the sense that it involves a variety of associated
neurological dysfunctions. All of the FOXP2 coding regions,
or exons, have since been screened for association with SLI,
using 43 SLIC probands, but no associations or mutations
were detected in this study [28]. It is likely, then, that the
FOXP2 gene remains functional in typical SLI probands.
Despite this, the FOXP2 gene is clearly vital for language
acquisition, as demonstrated by the KE phenotype [26]. The
KE phenotype has since been described as childhood apraxia
of speech (CAS), which has been linked to disruptive variants
within FOXP2, as demonstrated by similarly affected families
[29–32]. Subsequent studies of CAS also identified 16 sub-
microscopic deletions and duplications (copy number variants
[CNVs]) in half of the participants [33]. These fell across ten
different chromosomes and have the potential to cause disrup-
tions in speech and language development. Of note, overlap-
ping deletions at chromosome 16p13.2 were found in two of
the participants, though the region does not overlap with
previously implicated loci on chromosome 16, and the phe-
notypes associated with CNVs in this region have not been
characterised [33]. High-throughput sequencing methods
have also been applied to individuals affected by CAS [34].
Although this study sequenced the entire exomes (i.e. all
known gene-coding regions) of ten CAS probands, it reported
only mutations that affected known candidate genes. The
study reported potentially clinically relevant variants (i.e.
those variants that were predicted to have a deleterious effect
upon protein function and had a reported population frequen-
cy of <0.3 %) in eight of the ten individuals investigated.
These were distributed across six candidate genes that had
previously been associated with CAS (FOXP1 [forkhead box
P1], CNTNAP2 [contactin associated protein-like 2]) or over-
lapping phenotypes (ATP13A4 [ATPase type 13A4], CNTN
AP1 [contactin associated protein 1], KIAA0319 and SETX
[senataxin]) but did not include any FOXP2 mutations [34].
Although preliminary, the findings of this study suggest that
the application of high-throughput methodologies and
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comprehensive analyses of the arising data may prove fruitful
in future studies of speech and language impairments.
In 2010, a linkage study was conducted on a three-
generation German family, the NE family, with multiple mem-
bers affected by variable language and literacy impairments
[23]. Psychoacoustic tests demonstrated an auditory process-
ing deficit that co-segregated with these impairments. The
investigators hypothesised that this deficit disallowed the
affected family members to discriminate between tone dura-
tions, putting them at an increased risk of language-related
disorders. Linkage analysis suggested that a large 58.5 Mb
region, containing 600 genes, on chromosome 12p13.31–
12q14.3 may contain a contributory variant, but the specific
variant has yet to be identified [23].
Another independent linkage study investigated an isolated
Chilean population with an increased prevalence of SLI. A
series of language tests indicated that ~35 % of the island’s
children met criteria for SLI, and a further 27.5 % had im-
paired language skills accompanied by other neurological
deficits [12]. Parametric and non-parametric linkage analyses
found consistent linkage to a 48 Mb stretch of chromosome
7q31–q36 (LOD score 6.73; P=4.0×10−11), which included
the genes FOXP2 and CNTNAP2 (OMIM 604569) [12], the
significance of which is discussed later in this article. No
single co-segregating chromosome regions were identified
using parametric linkage analyses, which supports the likeli-
hood of a polygenic aetiology of SLI in this population.
A recent linkage study detected a heterozygous 4 kb dele-
tion at chr2q36 (SLI5; OMIM 615432) in 15 Southeast Asian
probands with language delay and white-matter hyper-inten-
sities (WMH), which are commonmarkers of aging [25•]. The
deletion, which eliminated exon 3 of the TM4SF20 [trans-
membrane 4 L six family member 20] gene, co-segregated
with language delay in the 15 families studied and appeared to
represent an ancestral haplotype confined to Southeast Asian
populations, notably Vietnamese, Thai and Burmese, with an
allele frequency of ~1 % [25•]. The function of the TM4SF20
gene is unknown, and its function has yet to be assessed in
other SLI populations.
Another study described a geographically isolated,
Russian-speaking population with an increased prevalence
of SLI [35]. The settlement involves ~871 people, 20–40 %
of whom have language impairment [35]. At present, no
genetic studies have been conducted using this population,
but it is likely that the increased prevalence of SLI is caused by
a founder mutation that is now widespread amongst the set-
tlers, as seen in previous family and isolated-population stud-
ies of language impairment [12, 23, 25•].
Populations with an increased prevalence of language im-
pairment can assist with the identification of candidate genes.
It is assumed that the causative variant will be found more
commonly within the affected population and will thus be
easier to associate with the impairment. Future studies would
benefit from investigating the role of the candidate genes that
have been identified in these populations.
SLI Targeted Association Studies
Several studies have suggested shared genetic aetiology of
speech disorders and reading disability (RD)—in particular,
Speech Sound Disorder (SSD)—which is distinct from SLI
but is rarely treated as such. SSD is considered to be a problem
associated with phonological awareness, which leads to a
deficit in age-appropriate speech sound production [36].
Targeted linkage studies have identified significant linkage
for SSD within RD candidate regions. These include chromo-
somes 6p22, 15q21 (DYX1; OMIM 127700), 1p36 (DYX8;
OMIM 608995) [36] and 3p12–q13 (SSD; OMIM 608445
and DYX5; OMIM 606896) [37]. A more recent study carried
out GWLA in a large pedigree, exhibiting familial SSD and a
motor sequencing deficit. The study identified linkage peaks
on chromosomes 6p21, 7q32, 7q36 (overlapping with SLI4)
and 8q24 primarily with the motor sequencing phenotype, and
on 7q31.q32–34 with SSD [38].
A recent study also investigated whether autism and SLI
share genetic risk factors, by conducting linkage analysis in 79
families affected by SLI and/or autism. Two linkage peaks
were found on chromosomes 15q23–26, relating to oral lan-
guage ability, and 16p12, relating to written language ability,
within the subset of families that included individuals with
both autism and SLI. However, neither linkage peak was
independently associated with one disorder, indicating that
each locus influenced both SLI and autism [39•].
Although the numbers of studies in this field are relatively
small and consider only targeted regions, the findings indicate
a high level of heterogeneity and the involvement of many
contributory factors in language disorders. Following the dis-
covery of SLI linkage regions, the subsequent targeted studies
in this field aimed to narrow down those broad regions to
allow identification of specific risk variants. Targeted studies
have the advantage of investigating smaller regions with
greater marker density, and therefore resolution, making them
more powerful in detecting linkage and association.
A targeted association study, focusing on the chromosome
16q region [5, 6, 9, 22], pinpointed candidate genes for SLI
[11]. The SLI1 region was screened using 1906 single nucle-
otide polymorphisms (SNPs) across 58 genes. Two clusters of
variants were significantly associated with NWR and fell
within CMIP (c-maf-inducing protein) at rs6564903 (P=
5.5×10−7) and ATP2C2 (calcium-transporting ATPase type
2C) at rs11860694 (P=2.0×10−5). These findings suggest that
CMIP and ATP2C2 are somehow involved in developing, or
retaining, phonological short-term memories, which may be
important for language acquisition [11]. Note that since the
function of the identified variants remains unknown, it is
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possible that their effects are exerted through transcripts other
than ATP2C2 and CMIP.
In addition, a study by Lonardo et al. presented a
patient with postural, motor and speech delay, and se-
vere learning and behavioural difficulties [40]. They
established that the patient possessed an inverted de
novo tandem duplication of 16q22q11.2, although they
could not establish a true correlation of genotype to
phenotype, because of the size of the duplication [40].
The findings of this study support the implications that
a region of chromosome 16 plays an important role in
the development of speech and language. Although the
duplication at 16q22q11.2 that was observed in this
study does not include CMIP (16q23.2) and ATP2C2
(16q24.1), it does suggest that chromosome 16 may
include a number of genes that influence the develop-
ment of language [5, 6, 9, 11, 22, 40].
An additional gene on chromosome 7q35–q36, known as
CNTNAP2 (which is down-regulated by FOXP2 [10]), has
also been associated with SLI. A functional study identified a
CNTNAP2 fragment that was bound by the FOXP2 protein,
regulating its expression. A targeted association analysis in the
SLIC cohort identified significant associations between NWR
and nine intronic SNPs in CNTNAP2 [10]. A subsequent
association study supported the link between variants within
the same region of CNTNAP2 and language ability in a
general population sample [41].
Recently, a targeted association study considered the role
of the HLA region on chromosome 6p, which is important for
the function of the immune system, in SLI [42]. Among the
genes implicated in the study, which included both quan-
titative and case–control analyses, were HLA-A (major
histocompatibility complex, class I, A), HLA-B (major
histocompatibility complex, class I, B) and HLA-DRB1
(major histocompatibility complex, class II, DR beta 1),
which were previously implicated in autism [43], atten-
tion-deficit/hyperactivity disorder (ADHD) [44, 45] and
schizophrenia [46].
In summary, five regions have consistently been associated
with SLI, using GWLA, and targeted association studies have
enabled identification of risk variants and candidate genes
within three of these regions [13, 47] (see Table 1).
More recent publications in the language impairment
field have begun to incorporate high-throughput SNP
bead/chip assays to conduct genome-wide association
studies (GWAS) of SLI and related traits [14•, 48, 49].
GWAS of Language Impairment
GWAS offer a high-resolution scan of a growing num-
ber of consistently variable loci within the genome and
have been empowered by the development of genetic
variation databases, such as the HapMap project [50]
and the 1000 Genomes Project [51]. GWAS are con-
ducted using SNP arrays and compare the frequencies
of hundreds of thousands common di-allelic SNPs be-
tween affected and unaffected individuals. Under the
common-disorder, common-variant hypothesis, accumu-
latively, these common SNPs may predispose individ-
uals to various genetically complex diseases, including
SLI. Thus GWAS methods are an ideal, and cost-effec-
tive, way of pinpointing possible risk variants.
Compared with other neurodevelopmental disorders, rel-
atively few GWAS have been performed for SLI. Tradi-
tional case–control association studies typically require
thousands of cases and controls [52] to gather adequate
power, but at present no SLI cohort reaches this size. It
may be possible to employ family-based association
methods, which can use information from parents as well
as probands and may provide increased power. For exam-
ple, Weinberg et al. developed a method that uses case–
parents trios and obtained moderate power when testing
for child genetic effects using 100 case–parents trios and
high power when testing for parent-of-origin effects (with
effect sizes ranging between 2 and 3) [53]. In addition,
despite being underpowered, smaller cohorts may still
detect true associations that contribute across disorder
populations [54]. A recent study performed a GWAS using
the SLIC cohort [14•]. This study used family subsets
(e.g. case–parents trios) in a multinomial association meth-
od which compares the likelihoods of null and risk models
[55]. This approach allows for greater power when using
parents and offers flexibility in the type of analysis per-
formed. This particular study considered parent-of-origin
effects, in addition to the more commonly considered
child genotype model, and used quantitative language
measures to assign SLI affection status. The authors found
genome-wide significant paternal parent-of-origin effects
with a SNP in NOP9 [nucleolar protein 9] (P=3.74×
10−8) on chromosome 14q12 and suggestive maternal
parent-of-origin effects on chromosome 5p13 (P=1.16×
10−7) in a linkage region previously implicated in autism
[56] and ADHD [57]. The NOP9 gene codes for an RNA-
binding protein [58], which was shown to be dysregulated
in schizophrenia patients [59]. The Avon Longitudinal
Study of Parents and their Children (ALSPAC) population
cohort was used to replicate the maternal association on
chromosome 5; paternal genotypes were unavailable (P=
0.001), albeit in the opposite direction (i.e. the risk allele
was different).
As discussed above, children with SLI often have
other language disorders, or learning disorders, such as
RD, SSD, ADHD or autism, which suggests that there
may be an overlap of genetic risk factors [13, 60–62]. It
may therefore be beneficial to combine cohorts to investigate
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language disorders together and increase the sample sizes. In a
study of educational attainment, Rietveld et al. demonstrated
that the size of a cohort can outweigh a strict phenotype
selection in defining the underlying genetic aetiology of a
Table 1 A summary of specific language impairment (SLI) linkage in OMIM
Region Cytogenetic loci Associated gene(s) OMIM no. Method References
SLI1 16q23.1–16q24 CMIP; ATP2C2 606711 GWLA, targeted association [4, 5, 10]
SLI2 19q13.13–19q13.41 N/A 606712 GWLA [4, 5]
SLI3 13q14.3–13q31.1 N/A 607134 GWLA [6, 7]
SLI4 7q31–7q36 CNTNAP2 612514 GWLA, targeted association [4, 5, 9]
SLI5 2q36 TM4SF20 615432 LA [25•]
ATP2C2 calcium-transporting ATPase type 2C, CMIP c-maf-inducing protein, CNTNAP2 contactin associated protein-like 2, GWLA genome-wide
linkage analysis, LA linkage analysis, N/A not applicable, TM4SF20 transmembrane 4 L six family member 20
Fig. 1 A diagrammatic representation of specific language impairment (SLI) linkage regions and associations
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disorder [63]. In a similar approach, more recent language
impairment studies have utilised GWAS methods to investi-
gate overlapping genetic risk factors between learning
disorders.
GWAS Involving Disorders that Co-occur with SLI
Two GWAS of language-related traits in population samples
have been reported. The first examined reading and language-
related traits across the entire range in two independent pop-
ulation cohorts (the Brisbane Adolescent Twin Sample
[BATS] and ALSPAC) [64] and then went on to perform a
meta-analysis. The most significant association was with a
SNP in ABCC13 [ATP-binding cassette, sub-family C
(CFTR/MRP) member 13] (P=7.34×10−8 in the combined
cohort) on chromosome 21q11.2. ABCC13 (OMIM 608835)
is thought to be a pseudogene that used to be involved with
transporting molecules across intra- and extracellular mem-
branes [64]. A second study also used the ALSPAC cohort but
selected individuals for low language and/or reading skills
from this sample set and compared allele frequencies within
these subsets with the rest of the ALSPAC distribution [48].
The authors reported associations when considering individ-
uals with concurrent RD and language impairment in
ZNF385D [zinc finger protein 385D] (P=5.45×10−7) on
chromosome 3p24.3 and COL4A2 (collagen, type IV, alpha
2) [OMIM 120090] (P=7.59×10−7) on chromosome 13q34.
When examining individuals with only language impairment,
the strongest association was reported for a SNP on chromo-
some 4q26, in NDST4 (N-deacetylase/N-sulfotransferase
(heparan glucosaminyl) 4) [OMIM 615039] (P=1.4×10−7).
Very recently, Gialluisi et al. conducted a GWAS meta-
analysis involving individuals with both reading and language
impairments [65]. This study included 1,862 individuals from
families affected by RD or SLI in the UK Reading Disability
(UK-RD), SLIC and Colorado Learning Disabilities Research
Centre (CLDRC) databases. A family-based GWAS was per-
formed on sibling pairs from each of the three datasets before
combining all of the samples and conducting a meta-analysis.
Two SNPs, rs59197085 on chromosome 7q32.1 and
rs5995177 on chromosome 22q12.3, were found to be asso-
ciated at a suggestive level (P≈10−7) with a range of reading
and language traits [65]. rs59197085 falls within the
CCDC136 (coiled-coil domain containing 136) gene and falls
within the SLI4 region of linkage. rs5995177 lies within the
RBFOX2 (RNA-binding protein, fox-1 homolog 2) gene,
which is heavily expressed in the neurons of the developing
foetal brain [66]. RBFOX2 has been implicated in many
neurological disorders, including Rolandic epilepsy [67] and
autism [68]. In addition, RBFOX2 is both a FOXP2 target [69]
and part of a cascade of genes that interact with the DYX1C1
(dyslexia susceptibility 1 candidate 1) gene [70, 71]. This
study did not replicate the associations found in ATP2C2,
CMIP or CNTNAP2. This is likely due to the inclusion of
multiple affection phenotypes—language, reading and learn-
ing disability [65]. The combination of all of those phenotypes
would likely increase genetic heterogeneity and lead to weak-
er associations with specific components, although the authors
sought to overcome this limitation by implementing a princi-
pal component approach.
Conclusion
Linkage and association studies have highlighted a number of
genetic regions that may predispose individuals to SLI, as
summarised in Table 1. Targeted association studies have been
particularly successful in narrowing linkage regions into can-
didate genes, ofwhich there are now four to consider (Table 1).
More recently, GWAS have been used to identify SNPs that
might contribute to language ability or predispose individuals
to language impairment, successfully highlighting additional
genes for consideration. However, there is currently very little
overlap in the findings between these various studies (Fig. 1).
Future studies concerning SLI would benefit from functional
studies, determining the role of candidate genes and risk
variants that have been identified to date. These studies will
allow us to identify exactly how the risk variants predispose
individuals to language impairment and help elucidate the
pathways underlying such complex disorders. In addition, it
is clear that future studies will benefit from larger sample
sizes, clearer definitions of SLI, more consistent selection
criteria and investigation of related phenotypes. Neuroimag-
ing studies, for example, have been very successful in identi-
fying brain regions that are important for language and are
noticeably altered in language-impaired individuals [72–74].
Such b io log i ca l marke r s may prove use fu l a s
endophenotypes, representing altered brain activation patterns
and structural volumes that correlate with language impair-
ment and RD candidate gene dysfunction [48, 75]. It is also
likely that we will start to see data from whole-genome and
exome sequencing studies that will complement existing link-
age and association studies, as evidenced by preliminary
studies in CAS [34]. Sequencing methods can offer greater
power to detect rare and common variants, even if they have
only small effect sizes, but still require large sample sizes and
careful controls for reliable identification of candidate genes
[76]. Ultimately, in combination with the other methodologies
and criteria described in this article, whole-genome and exome
sequencing will assist with the identification of novel candi-
date genes and variants that may contribute to the risk of
developing SLI; this may lead to earlier clinical intervention.
The combination of data and expertise across these diverse
disciplines will enable better understanding of the biological
basis of language impairment.
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